Berberine
- Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 2008. View on PubMed
- Lan J, Zhao Y, Dong F, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. Journal of Ethnopharmacology, 2015. View on PubMed
Ceylon Cinnamon
- Allen RW, Schwartzman E, Baker WL, et al. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Annals of Family Medicine, 2013. View on PubMed
Banaba (Corosolic Acid)
- Miura T, Takagi S, Ishida T. Management of diabetes and its complications with banaba (Lagerstroemia speciosa L.) and corosolic acid. Evidence-Based Complementary and Alternative Medicine, 2012. View on PubMed
Saffron (Crocus sativus)
- Milajerdi A, Djafarian K, Hosseini B. The toxicity of saffron (Crocus sativus L.) and its constituents against normal and cancer cells. Journal of Nutrition & Intermediary Metabolism, 2016. View on PubMed
Olive Leaf (Oleuropein)
- de Bock M, Derraik JG, Brennan CM, et al. Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial. PLoS ONE, 2013. View on PubMed
Fucoxanthin (Laminaria japonica)
- Maeda H, Hosokawa M, Sashima T, et al. Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Molecular Medicine Reports, 2009. View on PubMed
These references are provided for informational purposes only and do not imply that GutGlucose treats, cures, or prevents any condition.